SPRING BK PHARMACEUTICALS IN's ticker is SBPH and the CUSIP is 849431101. A total of 56 filers reported holding SPRING BK PHARMACEUTICALS IN in Q1 2019. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2020 | $78,000 | -11.4% | 58,405 | -2.5% | 0.01% | -11.1% |
| Q2 2020 | $88,000 | +14.3% | 59,905 | -28.0% | 0.01% | -10.0% |
| Q1 2020 | $77,000 | -47.6% | 83,238 | -10.2% | 0.01% | -33.3% |
| Q4 2019 | $147,000 | -84.7% | 92,738 | -66.2% | 0.02% | -85.6% |
| Q3 2019 | $960,000 | -6.2% | 274,263 | -1.1% | 0.10% | -7.1% |
| Q2 2019 | $1,023,000 | -64.8% | 277,263 | +0.1% | 0.11% | -64.8% |
| Q1 2019 | $2,905,000 | +0.8% | 276,963 | -0.1% | 0.32% | -10.2% |
| Q4 2018 | $2,882,000 | -13.8% | 277,363 | 0.0% | 0.35% | +0.6% |
| Q3 2018 | $3,342,000 | +0.3% | 277,363 | -1.4% | 0.35% | -6.6% |
| Q2 2018 | $3,332,000 | -23.1% | 281,213 | -0.1% | 0.38% | -25.2% |
| Q1 2018 | $4,331,000 | +14.3% | 281,623 | -0.1% | 0.50% | +19.4% |
| Q4 2017 | $3,789,000 | -20.1% | 281,928 | +0.1% | 0.42% | -24.5% |
| Q3 2017 | $4,744,000 | +27.1% | 281,728 | +2.2% | 0.56% | +22.9% |
| Q2 2017 | $3,733,000 | +79.6% | 275,728 | +18.1% | 0.46% | +73.0% |
| Q1 2017 | $2,078,000 | +33.3% | 233,443 | +19.6% | 0.26% | +27.1% |
| Q4 2016 | $1,559,000 | +47.5% | 195,165 | +74.6% | 0.21% | +43.8% |
| Q2 2016 | $1,057,000 | – | 111,810 | – | 0.14% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| BVF INC/IL | 785,950 | $9,314,000 | 0.91% |
| Morse Asset Management, Inc | 177,500 | $2,103,000 | 0.58% |
| PARSONS CAPITAL MANAGEMENT INC/RI | 281,213 | $3,332,000 | 0.38% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 73,000 | $860,000 | 0.33% |
| TIEDEMANN ADVISORS, LLC | 412,049 | $4,883,000 | 0.31% |
| Private Capital Advisors, Inc. | 52,335 | $620,000 | 0.19% |
| SECTORAL ASSET MANAGEMENT INC | 131,656 | $1,560,000 | 0.17% |
| Lee Financial Co | 18,750 | $222,000 | 0.05% |
| Baker Brothers Advisors | 373,144 | $4,422,000 | 0.03% |
| Alyeska Investment Group, L.P. | 200,000 | $2,370,000 | 0.02% |